Evergene, a 100 % subidiary of e-service provider MIT, and Stagen, a Tokyo-based service provider for clinical tests, have started their genetic analysis business „DearGene“. The focus is on genetic risk prediction of various life-style related diseases, female health management, food allergy and cancer. SNP analysis is handled by Takara Bio

Evergene press release, April 10, 2015